Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Patient Assistance Programs Encouraged By Medicare Part D Final Rule

Executive Summary

Pharmaceutical manufacturer patient assistance programs can be used to cover out-of-pocket costs for Medicare Part D enrollees, CMS says in its final implementing regulations for the drug benefit

You may also be interested in...



Manufacturer Part D Patient Assistance Should Be Cash, Not Donated Drugs

Manufacturers should provide financial assistance for Medicare Part D beneficiaries through cash donations to charities rather than by donating products, the Centers for Medicare & Medicaid Services says

Manufacturer Part D Patient Assistance Should Be Cash, Not Donated Drugs

Manufacturers should provide financial assistance for Medicare Part D beneficiaries through cash donations to charities rather than by donating products, the Centers for Medicare & Medicaid Services says

Part D Compliance: Formularies, Subsidies Will Be IG Enforcement Targets

The HHS Inspector General will be targeting formulary development, measurement of "true out of pocket" spending and employer subsidies in its oversight of the Medicare drug benefit

Related Content

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel